Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial
Year: 2023
Type: conference-abstract
Source: Blood
Authors: Xiaohui Suo, Dongmei Wang, Fang Zheng, Suping Zhang, Congcong Zhang, Yinling Li, Rui Shi, Yan Wu, Sisi Yang, Liyun Zhao, Zongjiu Jiao, Jie Liu, Ling Zhang, Ling Li, Zhihua Zhang, Xinxiao Lu, Linyu Yuan, Sifeng Gao, Jilei Zhang, Xingli Zhao, Guanchen Bai, Yingchang Mi, Kaiqi Liu
Institutions: Harrison International Peace Hospital, Guiyang Medical University, First Affiliated Hospital of Zhengzhou University, Xingtai People's Hospital, China National Pharmaceutical Group Corporation (China), Inner Mongolia People's Hospital, Affiliated Hospital of Chengde Medical College, Tianjin People's Hospital, Qingdao University, Taian City Central Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389246949